Agenda 2030 FEMA Detention Prison Park TOKEN Credit

CRISPR, Molecular Biology, Gene Editing
Human Augmentation, a SWISS BANK Eugenics Program of nano-techno-enslavement:
https://juxtaposition1.substack.com/p/crispr-molecular-biology-gene-editing

CRISPR Therapeutics AG is a Swiss-American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award (FOYA) award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel (formerly CTX001), was granted regulatory approval by the US Food and Drug Administration (FDA) in December 2023.

Please subscribe to my Substack Channel:
https://juxtaposition1.substack.com